Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$934K Buy
29,000
+3,200
+12% +$118K ﹤0.01% 733
2025
Q4
$1.09M Sell
25,800
-3,600
-12% -$145K ﹤0.01% 679
2025
Q3
$1.01M Sell
29,400
-2,600
-8% -$74.6K ﹤0.01% 679
2025
Q2
$865K Buy
32,000
+3,400
+12% +$98.5K ﹤0.01% 974
2025
Q1
$848K Buy
28,600
+2,100
+8% +$80K ﹤0.01% 928
2024
Q4
$1.05M Sell
26,500
-2,100
-7% -$79.5K ﹤0.01% 838
2024
Q3
$974K Sell
28,600
-5,400
-16% -$152K ﹤0.01% 921
2024
Q2
$737K Buy
34,000
+500
+1% +$10.5K ﹤0.01% 999
2024
Q1
$742K Buy
33,500
+200
+0.6% +$4.88K ﹤0.01% 1023
2023
Q4
$916K Sell
33,300
-1,400
-4% -$33.8K ﹤0.01% 940
2023
Q3
$774K Buy
34,700
+800
+2% +$20.6K ﹤0.01% 998
2023
Q2
$863K Sell
33,900
-1,600
-5% -$38.8K ﹤0.01% 988
2023
Q1
$791K Buy
35,500
+3,700
+12% +$89.4K ﹤0.01% 1048
2022
Q4
$754K Sell
31,800
-13,800
-30% -$321K ﹤0.01% 1072
2022
Q3
$756K Buy
45,600
+900
+2% +$20.3K ﹤0.01% 1075
2022
Q2
$889K Buy
44,700
+12,600
+39% +$255K ﹤0.01% 989
2022
Q1
$884K Buy
32,100
+2,300
+8% +$65.8K ﹤0.01% 1110
2021
Q4
$1.23M Hold
29,800
﹤0.01% 1000
2021
Q3
$1.38M Sell
29,800
-2,500
-8% -$109K 0.01% 902
2021
Q2
$1.29M Buy
32,300
+3,000
+10% +$128K ﹤0.01% 1010
2021
Q1
$1.57M Buy
29,300
+4,400
+18% +$253K 0.01% 850
2020
Q4
$1.22M Sell
24,900
-4,300
-15% -$199K ﹤0.01% 941
2020
Q3
$948K Buy
29,200
+24,900
+579% +$791K ﹤0.01% 957
2020
Q2
$111K Buy
4,300
+400
+10% +$9.97K ﹤0.01% 1770
2020
Q1
$94K Sell
3,900
-26,800
-87% -$675K ﹤0.01% 1690
2019
Q4
$857K Sell
30,700
-2,100
-6% -$54.4K ﹤0.01% 1026
2019
Q3
$787K Buy
32,800
+900
+3% +$23.9K ﹤0.01% 918
2019
Q2
$909K Sell
31,900
-2,000
-6% -$50K ﹤0.01% 875
2019
Q1
$848K Sell
33,900
-15,800
-32% -$302K ﹤0.01% 896
2018
Q4
$625K Sell
49,700
-19,600
-28% -$232K ﹤0.01% 1034
2018
Q3
$661K Buy
69,300
+28,400
+69% +$313K ﹤0.01% 1227
2018
Q2
$382K Buy
40,900
+3,700
+10% +$26K ﹤0.01% 1506
2018
Q1
$206K Hold
37,200
﹤0.01% 1488
2017
Q4
$242K Hold
37,200
﹤0.01% 1474
2017
Q3
$326K Hold
37,200
﹤0.01% 1460
2017
Q2
$309K Buy
37,200
+7,700
+26% +$62.8K ﹤0.01% 1444
2017
Q1
$270K Hold
29,500
﹤0.01% 1482
2016
Q4
$228K Buy
29,500
+15,469
+110% +$116K ﹤0.01% 1535
2016
Q3
$106K Buy
14,031
+12,131
+638% +$68.6K ﹤0.01% 1675
2016
Q2
$9K Hold
1,900
﹤0.01% 1891
2016
Q1
$10K Hold
1,900
﹤0.01% 1854
2015
Q4
$13K Hold
1,900
﹤0.01% 1871
2015
Q3
$8K Hold
1,900
﹤0.01% 1851
2015
Q2
$21K Hold
1,900
﹤0.01% 1814
2015
Q1
$13K Sell
1,900
-100
-5% -$819 ﹤0.01% 1776
2014
Q4
$19K Hold
2,000
﹤0.01% 1691
2014
Q3
$20K Hold
2,000
﹤0.01% 1737
2014
Q2
$34K Hold
2,000
﹤0.01% 1641
2014
Q1
$34K Hold
2,000
﹤0.01% 1645
2013
Q4
$29K Buy
+2,000
New +$26K ﹤0.01% 1684

Other funds holding VCYT

STRS Ohio's VCYT Position: Q1 2026 in Review

STRS Ohio increased its Veracyte (VCYT) stake by 12% in Q1 2026, buying an estimated $118K and bringing the position to 29,000 shares worth $934K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

STRS Ohio first reported a position in VCYT in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.57M in Q1 2021. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • STRS Ohio held 29,000 shares of Veracyte worth $934K as of Q1 2026.
  • STRS Ohio bought 3,200 Veracyte shares in Q1 2026, an estimated $118K.
  • Veracyte made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #733 holding.
  • STRS Ohio first reported a position in Veracyte in Q4 2013 and has held it in 50 quarters since.
  • STRS Ohio's Veracyte position peaked at $1.57M in Q1 2021.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.